Omote K, Namiki A, Iwasaki H, Ujike Y
Department of Anesthesiology, Sapporo Medical College and Hospital, Japan.
Can J Anaesth. 1991 Mar;38(2):210-2. doi: 10.1007/BF03008147.
Cimetidine, a histamine 2 (H2) antagonist, produces a decrease in arterial pressure due to vasodilatation, especially in critically ill patients. This may be because cimetidine acts as a histamine agonist. We, therefore, investigated the effects of the histamine 1(H1) receptor antagonist, diphenhydramine, on the haemodynamic changes observed after cimetidine in ICU patients. Each patient was studied on two separate days. In a random fashion, they received cimetidine 200 mg iv on one day, and on the other, a pretreatment of diphenhydramine 40 mg iv with cimetidine 200 mg iv. In the non-pretreatment group, mean arterial pressure (MAP) decreased from 107.4 +/- 8.4 mmHg to 86.7 +/- 11.4 mmHg (P less than 0.01) two minutes after cimetidine. Also, systemic vascular resistance (SVR) decreased during the eight-minute observation period (P less than 0.01). In contrast, in the pretreatment group, little haemodynamic change was seen. We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.
西咪替丁是一种组胺2(H2)拮抗剂,可导致动脉血压因血管舒张而下降,在危重症患者中尤为明显。这可能是因为西咪替丁起到了组胺激动剂的作用。因此,我们研究了组胺1(H1)受体拮抗剂苯海拉明对重症监护病房(ICU)患者使用西咪替丁后所观察到的血流动力学变化的影响。每位患者在两个不同的日子接受研究。以随机方式,他们在一天接受静脉注射200毫克西咪替丁,在另一天,先静脉注射40毫克苯海拉明预处理,然后再静脉注射200毫克西咪替丁。在未预处理组中,西咪替丁注射两分钟后,平均动脉压(MAP)从107.4±8.4毫米汞柱降至86.7±11.4毫米汞柱(P<0.01)。此外,在八分钟观察期内全身血管阻力(SVR)下降(P<0.01)。相比之下,预处理组几乎未见血流动力学变化。我们得出结论,H1拮抗剂可能有助于预防静脉注射西咪替丁引起的低血压,因为西咪替丁的血管舒张活性部分是通过H1受体介导的。